Discontinued — last reported Q1 '19
CVS Health AFS and Trading Securities - Unrealized Loss Position (>=12 Months) decreased by 11.5% to $3.66B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 44.4%, from $6.58B to $3.66B. Over 4 years (FY 2020 to FY 2024), AFS and Trading Securities - Unrealized Loss Position (>=12 Months) shows an upward trend with a 234.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher values suggest a significant portion of the portfolio is subject to prolonged market value depreciation.
The aggregate fair value of available-for-sale and trading debt securities that have been in an unrealized loss position...
Standard metric for assessing long-term investment portfolio health across the banking sector.
afs_debt_securities_unrealized_loss_12m_plus| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $43.00M | $151.00M | $584.00M | $1.05B | $1.09B | $2.49B | $4.26B | $9.57B | $10.18B | $11.68B | $10.62B | $9.66B | $8.96B | $6.58B | $5.73B | $5.04B | $4.14B | $3.66B |
| QoQ Change | — | +251.2% | +286.8% | +79.1% | +4.5% | +127.7% | +71.3% | +124.5% | +6.4% | +14.7% | -9.1% | -9.0% | -7.3% | -26.5% | -12.9% | -12.2% | -17.8% | -11.5% |
| YoY Change | — | — | — | — | >999% | >999% | +630.1% | +815.1% | +831.7% | +369.1% | +149.0% | +1.0% | -12.0% | -43.6% | -46.0% | -47.9% | -53.8% | -44.4% |